Virus Testing Diagnostic Kits Market Trends

  • Report ID: 2414
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Virus Testing Diagnostic Kits Market Trends

 Growth Drivers

Rising Cases of Newly Discovered Viruses to Boost the Market Growth

Since viruses are constantly mutating and new diseases are being continuously discovered, the demand for virus testing kits is high. For instance, the newly discovered coronavirus leads to one such respiratory disorder which might show symptoms between 2 to 14 days of infection. Further, the symptoms are similar to that of common cold which makes it harder to detect the disease at an early stage. As per the Centers for Disease Control and Prevention, the total cases of COVID-19 in the United States were 330,891 as of April 6, 2020 and with 8,910 total deaths. New virus testing kits are being developed in research laboratories all over the world which are able to detect the new coronavirus. This is anticipated to significantly expand the market.

Globally Improving Healthcare Infrastructure to Drive the Market Growth

The healthcare infrastructure all over the world is improving at a fast pace owing to the increasing number of cases of various diseases which results in a growing demand for better healthcare services, facilities and equipment at clinics and hospitals. The growing research and development for treatment methods at research laboratories further fuels the healthcare industry. On the back of these, the market is predicted to grow over the forecast period.

Challenges

Lack of Required Equipment and Skilled Labor to Hamper the Market Growth

Despite the improving healthcare infrastructure, there is a shortage of necessary equipment in order to meet the growing demand globally as well as lack of skilled labor in the research and development area. This is estimated to hinder the growth of market in the future. 

Virus Testing Kits Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2414
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of diseases arising as a result of newly discovered viruses and improving healthcare infrastructure is driving the market growth

The market is anticipated to attain a significant CAGR over the forecast period, i.e. 2020-2028.

Asia Pacific region is predicted to provide more business opportunities for growth on account of of developing healthcare infrastructure, growing research activities and improving healthcare facilities in the region.

The major players in the market are F. Hoffmann-La Roche Ltd, Qiagen, Abbott, Thermo Fisher Scientific, Becton, Dickinson and Company, BioMérieux SA, Quidel Corporation, Rapikit, Zoetis Inc. and Luminex Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample